Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Vanda Pharmaceuticals · NCT05648591
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12–17 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 4
- Target enrollment
- 100
- US sites recruiting
- 11
- Study start
- May 24, 2023
- Record last updated
- October 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Being studied: Iloperidone
Conditions: Schizophrenia; Bipolar I Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patient is willing and able to provide assent and willing to complete all aspects of the study
- Patient's parent or legal guardian willing and able to provide consent
- Male or female patients 12 through 17 years of age (inclusive)
- Clinical diagnosis of either schizophrenia or bipolar I disorder
Exclusion Criteria
- Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer
- A positive test for drugs of abuse
Recruiting US locations
Vanda Investigational Site
Dothan, AL 36303
Site contact: 202-734-3400
Vanda Investigational Site
Little Rock, AR 72204
Site contact: 202-734-3400
Vanda Investigational Site
Denver, CO 80202
Site contact: 202-734-3400
Vanda Investigational Site
Atlanta, GA 30318
Site contact: 202-734-3400
Vanda Investigational Site
Atlanta, GA 30331
Site contact: 202-734-3400
Vanda Investigational Site
Decatur, GA 30030
Site contact: 202-734-3400
Vanda Investigational Site
Kinston, NC 28501
Site contact: 202-734-3400
Vanda Investigational Site
Cincinnati, OH 45221
Site contact: Vanda Pharmaceuticals · 202-734-3400
Vanda Investigational Site
Garfield Heights, OH 44125
Site contact: 202-734-3400
Vanda Investigational Site
Westlake, OH 44145
Site contact: 202-734-3400
Vanda Investigational Site
Everett, WA 98201
Site contact: 202-734-3400
Study contacts (from the official record)
- Vanda Pharmaceuticals Inc. · 202-734-3400 · clinicaltrials@vandapharma.com
Similar studies in Alabama
All mental health studies in Alabama →- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Birmingham, AL + 50 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With…
LivaNova
- Location
- Birmingham, AL + 49 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Abbott Medical Devices
- Location
- Birmingham, AL + 24 other US sites
- Eligibility basics
- Ages 22–70
- RecruitingPhase 3
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
- Location
- Birmingham, AL + 27 other US sites
- Eligibility basics
- Ages 18–85